|
1
|
Shi X, Tian L, Zhu XD, Wang HM and Qin H:
Effect of Chinese drugs combining with chemotherapy on quality of
life in 146 children with solid tumor. Chin J Integr Med. 17:31–34.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Müller HL, Oh Y, Lehrnbecher T, Blum WF
and Rosenfeld RG: Insulin-like growth factor-binding protein-2
concentrations in cerebrospinal fluid and serum of children with
malignant solid tumors or acute leukemia. J Clin Endocrinol Metab.
79:428–434. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duan W, Jin X, Xiu Y, et al: Expression of
the novel all-trans retinoic acid-related resistance gene HA117 in
pediatric solid tumors. J Pediatr Hematol Oncol. 36:45–50. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Körbling M and Freireich EJ: Twenty-five
years of peripheral blood stem cell transplantation. Blood.
117:6411–6416. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sheridan WP, Morstyn G, Wolf M, et al:
Granulocyte colony-stimulating factor and neutrophil recovery after
high-dose chemotherapy and autologous bone marrow transplantation.
Lancet. 2:891–895. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nademanee A, Sniecinski I, Schmidt GM, et
al: High-dose therapy followed by autologous peripheral-blood
stem-cell transplantation for patients with Hodgkin's disease and
non-Hodgkin's lymphoma using unprimed and granulocyte
colony-stimulating factor-mobilized peripheral-blood stem cells. J
Clin Oncol. 12:2176–2186. 1994.PubMed/NCBI
|
|
7
|
Bensinger WI, Clift R, Martin P, et al:
Allogeneic peripheral blood stem cell transplantation in patients
with advanced hematologic malignancies: a retrospective comparison
with marrow transplantation. Blood. 88:2794–2800. 1996.PubMed/NCBI
|
|
8
|
Körbling M, Fliedner TM, Holle R, et al:
Autologous blood stem cell (ABSCT) versus purged bone marrow
transplantation (pABMT) in standard risk AML: influence of source
and cell composition of the autograft on hemopoietic reconstitution
and disease-free survival. Bone Marrow Transplant. 7:343–349.
1991.PubMed/NCBI
|
|
9
|
Mehta J, Powles R, Singhal S and Treleaven
J: Peripheral blood stem cell transplantation may result in
increased relapse of acute myeloid leukaemia due to reinfusion of a
higher number of malignant cells. Bone Marrow Transplant.
15:652–653. 1995.PubMed/NCBI
|
|
10
|
Reiffers J, Korbling M, Labopin M, Henon P
and Gorin NC: Autologous blood stem cell transplantation versus
autologous bone marrow transplantation for acute myeloid leukemia
in first complete remission. Int J Cell Cloning. 10 (Suppl
S1):111–113. 1992. View Article : Google Scholar
|
|
11
|
Demirer T, Petersen FB, Bensinger WI, et
al: Autologous transplantation with peripheral blood stem cells
collected after granulocyte colony-stimulating factor in patients
with acute myelogenous leukemia. Bone Marrow Transplant. 18:29–34.
1996.PubMed/NCBI
|
|
12
|
Gignac GA and Wexler LH: Effects of
therapy for solid tumorsFertility Preservation in Male Cancer
Patients. Mulhall JP: Cambridge University Press; Cambridge: pp.
119–128. 2013, View Article : Google Scholar
|
|
13
|
Taurin S and Greish K: Enhanced vascular
permeability in solid tumors: a promise for anticancer
nanomedicineTight Junctions in Cancer Metastasis. Martin TA and
Jiang WG: Springer; Dordrecht: pp. 81–118. 2013
|
|
14
|
Cesaro S, Nesi F, Tridello G, et al: A
randomized, non-inferiority study comparing efficacy and safety of
a single dose of pegfilgrastim versus daily filgrastim in pediatric
patients after autologous peripheral blood stem cell transplant.
PloS One. 8:e532522013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eto T, Takase K, Miyamoto T, et al:
Autologous peripheral blood stem cell transplantation with
granulocyte colony-stimulating factor combined conditioning regimen
as a postremission therapy for acute myelogenous leukemia in first
complete remission. Int J Hematol. 98:186–196. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pulsipher MA, Chitphakdithai P, Logan BR,
et al: Acute toxicities of unrelated bone marrow versus peripheral
blood stem cell donation: results of a prospective trial from the
National Marrow Donor Program. Blood. 121:197–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bearman SI, Appelbaum FR, Buckner CD, et
al: Regimen-related toxicity in patients undergoing bone marrow
transplantation. J Clin Oncol. 6:1562–1568. 1988.PubMed/NCBI
|
|
18
|
Corrias MV, Haupt R, Carlini B, et al:
Peripheral blood stem cell tumor cell contamination and survival of
neuroblastoma patients. Clin Cancer Res. 12:5680–5685. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Widemann BC, Salzer WL, Arceci RJ, et al:
Phase I trial and pharmacokinetic study of the farnesyltransferase
inhibitor tipifarnib in children with refractory solid tumors or
neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol.
24:507–516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Crist WM and Kun LE: Common solid tumors
of childhood. N Engl J Med. 324:461–471. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hartmann O, Benhamou E, Beaujean F, et al:
High-dose busulfan and cyclophosphamide with autologous bone marrow
transplantation support in advanced malignancies in children: a
phase II study. J Clin Oncol. 4:1804–1810. 1986.PubMed/NCBI
|
|
23
|
Green DM, Kun LE, Matthay KK, et al:
Relevance of historical therapeutic approaches to the contemporary
treatment of pediatric solid tumors. Pediatr Blood Cancer.
60:1083–1094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Macy ME, Duncan T, Whitlock J, et al: A
multi-center phase Ib study of oxaliplatin (NSC#266046) in
combination with fluorouracil and leucovorin in pediatric patients
with advanced solid tumors. Pediatr Blood Cancer. 60:230–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kwon SY, Won SC, Han JW, Shin YJ and Lyu
CJ: Feasibility of sequential high-dose chemotherapy in advanced
pediatric solid tumors. Pediatr Hematol Oncol. 27:1–12. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kushner BH, Kramer K, Meyers PA, Wollner N
and Cheung NK: Pilot study of topotecan and high-dose
cyclophosphamide for resistant pediatric solid tumors. Med Pediatr
Oncol. 35:468–474. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hoffman JA, Shah AJ, Ross LA and Kapoor N:
Adenoviral infections and a prospective trial of cidofovir in
pediatric hematopoietic stem cell transplantation. Biol Blood
Marrow Transplant. 7:388–394. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ljungman P, Deliliers GL, Platzbecker U,
et al: Cidofovir for cytomegalovirus infection and disease in
allogeneic stem cell transplant recipients. The Infectious Diseases
Working Party of the European Group for Blood and Marrow
Transplantation. Blood. 97:388–392. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Klein HG, Spahn DR and Carson JL: Red
blood cell transfusion in clinical practice. Lancet. 370:415–426.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sevilla J, González-Vicent M, Madero L,
García-Sánchez F and Angel Diaz M: Large volume leukapheresis in
small children: safety profile and variables affecting peripheral
blood progenitor cell collection. Bone Marrow Transplant.
31:263–267. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Balduzzi A, Gooley T, Anasetti C, et al:
Unrelated donor marrow transplantation in children. Blood.
86:3247–3256. 1995.PubMed/NCBI
|
|
32
|
Okamoto Y, Takaue Y, Saito S, et al:
Toxicities associated with cryopreserved and thawed peripheral
blood stem cell autografts in children with active cancer.
Transfusion. 33:578–581. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Attarian H, Feng Z, Buckner CD, MacLeod B
and Rowley SD: Long-term cryopreservation of bone marrow for
autologous transplantation. Bone Marrow Transplant. 17:425–430.
1996.PubMed/NCBI
|
|
34
|
Wingard JR, Merz WG, Rinaldi MG, Johnson
TR, Karp JE and Saral R: Increase in Candida krusei
infection among patients with bone marrow transplantation and
neutropenia treated prophylactically with fluconazole. N Engl J
Med. 325:1274–1277. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Howell A, Gumpel JM and Watts RW:
Depression of bone marrow colony formation in gold-induced
neutropenia. Br Med J. 1:432–434. 1975. View Article : Google Scholar : PubMed/NCBI
|
